Functional Collaboration of Insulin-Like Growth Factor-1 Receptor (IGF-1R), but Not Insulin Receptor (IR), With Acute GH Signaling in Mouse Calvarial Cells

被引:10
|
作者
Gan, Yujun [1 ]
Paterson, Andrew J. [1 ]
Zhang, Yue [1 ]
Jiang, Jing [1 ]
Frank, Stuart J. [1 ,2 ,3 ,4 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA
[4] Vet Affairs Med Ctr, Med Serv, Endocrinol Sect, Birmingham, AL 35233 USA
基金
美国国家卫生研究院;
关键词
1ST; 3; DOMAINS; HORMONE RECEPTOR; SOMATOMEDIN HYPOTHESIS; PROSTATE CARCINOGENESIS; SPECIFICITY; OSTEOBLASTS; DISRUPTION; RAT; TRANSCRIPTION; DETERMINANTS;
D O I
10.1210/en.2013-1732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH signals through the GH receptor (GHR), a cytokine receptor linked to Janus kinase 2 (JAK2). GH activates signal transducer and activator of transcription 5 (STAT5), causing expression of genes including IGF-I. IGF-I binds IGF-I receptor (IGF-IR), a heterotetrameric (alpha(2)-beta(2)) tyrosine kinase growth factor receptor similar to insulin receptor (IR). In addition to this GH -> GHR -> IGF-I -> IGF-IR pathway, GH induces a complex including GHR, JAK2, and IGF-IR and deletion of floxed IGF-1R in primary murine calvarial cells with Cre-recombinase-expressing adenovirus (Ad-Cre) desensitizes cells to GH for STAT5 activation and IGF-I mRNA accumulation. Diminished GH-induced STAT5 phosphorylation in Ad-Cre-treated cells is rescued by adenoviruses encoding either IGF-IR or IGF-IR lacking the alpha-chain intracellular domain. Reasoning that IGF-IR's extracellular portion (alpha or extracellular beta) mediates functional interaction with GH signaling, we pursued reconstitution studies. Although structurally related to IGF-IR, IR expressed adenovirally did not rescue GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. We thus created chimeras, swapping homologous IR extracellular regions into IGF-IR. IR and IGF-IR possess N-terminal L1, cysteine-rich (CR), and L2 alpha-chain domains. We created Ad-IGF-IR/IR-L1 and Ad-IGF-IR/IR-L1-CR-L2, in which L1 alone or L1, CR, and L2 of IR replace corresponding IGF-IR regions, respectively. Ad-IGF-IR/IR-L1, but not Ad-IGF-IR/IRL1- CR-L2, rescued GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. Additionally, medium containing a soluble IGF-IR (including only L1-CR-L2) dampened GH-induced STAT5 phosphorylation in calvarial cells and two other GH-responsive cell lines. Thus, an extracellular determinant(s), likely in CR-L2, specifically allows IGF-IR to collaborate with GHR and JAK2 for robust GH-induced acute STAT5 phosphorylation.
引用
收藏
页码:1000 / 1009
页数:10
相关论文
共 50 条
  • [1] Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
    Buck, Elizabeth
    Gokhale, Prafulla C.
    Koujak, Susan
    Brown, Eric
    Eyzaguirre, Alexandra
    Tao, Nianjun
    Rosenfeld-Franklin, Maryland
    Lerner, Lorena
    Chiu, M. Isabel
    Wild, Robert
    Epstein, David
    Pachter, Jonathan A.
    Miglarese, Mark R.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (10) : 2652 - 2664
  • [2] Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
    Pushpendra Singh
    Jimi Marin Alex
    Felix Bast
    [J]. Medical Oncology, 2014, 31
  • [3] Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer
    Singh, Pushpendra
    Alex, Jimi Marin
    Bast, Felix
    [J]. MEDICAL ONCOLOGY, 2014, 31 (01)
  • [4] The Expression of Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Early Breast Cancer
    Spears, M.
    Cunningham, C. A.
    Thomas, J. J.
    Kerr, G. R.
    Jack, W. L.
    Campbell, F. M.
    McKay, L.
    Kunkler, I. H.
    Cameron, D. A.
    Chetty, U.
    Bartlett, J. M. S.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 634S - 634S
  • [5] Insulin growth factor 1 like receptor (IGF-1R)
    Iyer, Gopal
    Price, James
    Bourgeois, Shay
    Armstrong, Eric
    Huang, Shyhmin
    Harari, Paul M.
    [J]. BMC CANCER, 2016, 16
  • [6] Insulin growth factor 1 like receptor (IGF-1R)
    Gopal Iyer
    James Price
    Shay Bourgeois
    Eric Armstrong
    Shyhmin Huang
    Paul M. Harari
    [J]. BMC Cancer, 16
  • [7] Antisense Oligonucleotide Targeting of Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Prostate Cancer
    Furukawa, Junya
    Wraight, Christopher J.
    Freier, Susan M.
    Peralta, Eigan
    Atley, Lynne M.
    Monia, Brett P.
    Gleave, Martin E.
    Cox, Michael E.
    [J]. PROSTATE, 2010, 70 (02): : 206 - 218
  • [8] Targeting the insulin-like growth factor-1 receptor (IGF-1R) in the treatment of metastazising uveal melanoma
    Ericsson, CB
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U514 - U514
  • [9] Epidermal insulin receptor (IR) and Insulin like growth factor-1 (IGF-1R) receptor are essential on maintenance epidermal morphogenesis and proliferative potential
    Stachelscheid, H.
    Schmitz, A.
    Bruening, J. C.
    Niessen, C. M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S60 - S60
  • [10] HoxA9 induces insulin-like growth factor-1 receptor (IGF-1R) expression in acute leukemia
    Whelan, Jarrett T.
    Ludwig, Dale L.
    Bertrand, Fred E.
    [J]. BLOOD, 2007, 110 (11) : 981A - 982A